[Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules].

T Rüdiger, I Bonzheim, E Geissinger, S Roth, A Zettl, A Marx, A Rosenwald, H K Müller-Hermelink
{"title":"[Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules].","authors":"T Rüdiger,&nbsp;I Bonzheim,&nbsp;E Geissinger,&nbsp;S Roth,&nbsp;A Zettl,&nbsp;A Marx,&nbsp;A Rosenwald,&nbsp;H K Müller-Hermelink","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Anaplastic large cell lymphoma (ALCL) designates a heterogeneous group of CD30+ (systemic or primary cutaneous) peripheral T-cell lymphomas (PTCLs). A subgroup of systemic ALCL is transformed by anaplastic lymphoma kinase (ALK). We compared 46 ALCL with 22 PTCLs in terms of T-cell receptor (TCR) rearrangements, expression of TCRs and TCR-associated molecules [CD3, ZAP-70 (zeta-associated protein 70)]. Despite their frequent clonal rearrangement for TCRbeta, only 4% of ALCLs expressed TCRbeta protein, whereas TCRs were detected in 86% of PTCLs. Moreover, both TCRbeta+ ALCLs lacked CD3 and ZAP-70 (ie, molecules indispensable for the transduction of cognate TCR signals). Defective expression of TCRs is a common characteristic of all types of ALCL, which may contribute to the dysregulation of intracellular signaling pathways controlling T-cell activation and survival. This molecular hallmark of ALCL is analogous to defective immunoglobulin expression distinguishing Hodgkin lymphoma from other B-cell lymphomas.</p>","PeriodicalId":76792,"journal":{"name":"Verhandlungen der Deutschen Gesellschaft fur Pathologie","volume":"89 ","pages":"261-6"},"PeriodicalIF":0.0000,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Verhandlungen der Deutschen Gesellschaft fur Pathologie","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Anaplastic large cell lymphoma (ALCL) designates a heterogeneous group of CD30+ (systemic or primary cutaneous) peripheral T-cell lymphomas (PTCLs). A subgroup of systemic ALCL is transformed by anaplastic lymphoma kinase (ALK). We compared 46 ALCL with 22 PTCLs in terms of T-cell receptor (TCR) rearrangements, expression of TCRs and TCR-associated molecules [CD3, ZAP-70 (zeta-associated protein 70)]. Despite their frequent clonal rearrangement for TCRbeta, only 4% of ALCLs expressed TCRbeta protein, whereas TCRs were detected in 86% of PTCLs. Moreover, both TCRbeta+ ALCLs lacked CD3 and ZAP-70 (ie, molecules indispensable for the transduction of cognate TCR signals). Defective expression of TCRs is a common characteristic of all types of ALCL, which may contribute to the dysregulation of intracellular signaling pathways controlling T-cell activation and survival. This molecular hallmark of ALCL is analogous to defective immunoglobulin expression distinguishing Hodgkin lymphoma from other B-cell lymphomas.

[间变性大细胞淋巴瘤缺乏t细胞受体分子的表达]。
间变性大细胞淋巴瘤(ALCL)是一种异质性的CD30+(系统性或原发性皮肤)周围t细胞淋巴瘤(PTCLs)。系统性ALCL的一个亚群是由间变性淋巴瘤激酶(ALK)转化的。我们在t细胞受体(TCR)重排、TCR和TCR相关分子[CD3、ZAP-70 (ζ相关蛋白70)]的表达方面比较了46例ALCL和22例ptcl。尽管TCRbeta的克隆重排频繁,但只有4%的alcl表达TCRbeta蛋白,而在86%的ptcl中检测到TCRs。此外,两种TCRbeta+ ALCLs都缺乏CD3和ZAP-70(即同源TCR信号转导不可或缺的分子)。TCRs表达缺陷是所有ALCL类型的共同特征,这可能导致控制t细胞活化和存活的细胞内信号通路失调。ALCL的分子特征类似于区分霍奇金淋巴瘤和其他b细胞淋巴瘤的免疫球蛋白表达缺陷。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信